Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.

Gangliosides, such as GM2, GD2, GD3, and 9-O-acetyl GD3, are receiving attention as targets for antibody-based and vaccine-based therapies of melanoma. GM2 appears to be a particularly immunogenic ganglioside in humans, as indicated by the presence of naturally occurring IgM anti-GM2 antibodies in a...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Kitamura, K, Livingston, P O, Fortunato, S R, Stockert, E, Helling, F, Ritter, G, Oettgen, H F, Old, L J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC42307/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7708728/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.92.7.2805
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!